366 related articles for article (PubMed ID: 37259854)
21. Metal-Organic Frameworks for Drug Delivery: A Design Perspective.
Lawson HD; Walton SP; Chan C
ACS Appl Mater Interfaces; 2021 Feb; 13(6):7004-7020. PubMed ID: 33554591
[TBL] [Abstract][Full Text] [Related]
22. Advancements and Challenges in the Application of Metal-Organic Framework (MOF) Nanocomposites for Tumor Diagnosis and Treatment.
Hou Y; Zhu C; Ban G; Shen Z; Liang Y; Chen K; Wang C; Shi H
Int J Nanomedicine; 2024; 19():6295-6317. PubMed ID: 38919774
[TBL] [Abstract][Full Text] [Related]
23. Mn(II)-hemoporfin-based metal-organic frameworks as a theranostic nanoplatform for MRI-guided sonodynamic therapy.
Jiang Q; Xu H; Zhang W; Wang Y; Xia J; Chen Z
Biomater Sci; 2023 Dec; 11(24):7838-7844. PubMed ID: 37889225
[TBL] [Abstract][Full Text] [Related]
24. Aperture Modulation of Isoreticular Metal Organic Frameworks for Targeted Antitumor Drug Delivery.
Cai M; Liang W; Wang K; Yin D; Fu T; Zhu R; Qu C; Dong X; Ni J; Yin X
ACS Appl Mater Interfaces; 2022 Aug; 14(32):36366-36378. PubMed ID: 35897121
[TBL] [Abstract][Full Text] [Related]
25. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
26. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
27. Tunable metal-organic frameworks assist in catalyzing DNAzymes with amplification platforms for biomedical applications.
Zhu X; Xu J; Ling G; Zhang P
Chem Soc Rev; 2023 Oct; 52(21):7549-7578. PubMed ID: 37817667
[TBL] [Abstract][Full Text] [Related]
28. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
29. Recent Advances in Metal-Phenolic Networks for Cancer Theranostics.
Zhang Z; Xie L; Ju Y; Dai Y
Small; 2021 Oct; 17(43):e2100314. PubMed ID: 34018690
[TBL] [Abstract][Full Text] [Related]
30. Nanoscale MOFs in nanomedicine applications: from drug delivery to therapeutic agents.
Sun Z; Li T; Mei T; Liu Y; Wu K; Le W; Hu Y
J Mater Chem B; 2023 Apr; 11(15):3273-3294. PubMed ID: 36928915
[TBL] [Abstract][Full Text] [Related]
31. Zinc-Based Metal-Organic Frameworks in Drug Delivery, Cell Imaging, and Sensing.
Safdar Ali R; Meng H; Li Z
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011330
[TBL] [Abstract][Full Text] [Related]
32. Size-Controlled Synthesis of Drug-Loaded Zeolitic Imidazolate Framework in Aqueous Solution and Size Effect on Their Cancer Theranostics in Vivo.
Duan D; Liu H; Xu M; Chen M; Han Y; Shi Y; Liu Z
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42165-42174. PubMed ID: 30457318
[TBL] [Abstract][Full Text] [Related]
33. Metal-Organic Framework-Based Nanomedicines for Ferroptotic Cancer Therapy.
Song Y; Xu X; Wang Z; Zhao Y
Adv Healthc Mater; 2024 Apr; 13(11):e2303533. PubMed ID: 38221753
[TBL] [Abstract][Full Text] [Related]
34. Hierarchical self-assembly of magnetic nanoclusters for theranostics: Tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery.
Nguyen DH; Lee JS; Choi JH; Park KM; Lee Y; Park KD
Acta Biomater; 2016 Apr; 35():109-17. PubMed ID: 26884278
[TBL] [Abstract][Full Text] [Related]
35. Metal-Organic Framework Composites for Theragnostics and Drug Delivery Applications.
Osterrieth JWM; Fairen-Jimenez D
Biotechnol J; 2021 Feb; 16(2):e2000005. PubMed ID: 32330358
[TBL] [Abstract][Full Text] [Related]
36. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
Pan YB; Wang S; He X; Tang W; Wang J; Shao A; Zhang J
J Mater Chem B; 2019 Dec; 7(48):7683-7689. PubMed ID: 31778139
[TBL] [Abstract][Full Text] [Related]
37. Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications.
Lu K; Aung T; Guo N; Weichselbaum R; Lin W
Adv Mater; 2018 Sep; 30(37):e1707634. PubMed ID: 29971835
[TBL] [Abstract][Full Text] [Related]
38. Biodegradable Metal Organic Frameworks for Multimodal Imaging and Targeting Theranostics.
Lai X; Jiang H; Wang X
Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562889
[TBL] [Abstract][Full Text] [Related]
39. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
[TBL] [Abstract][Full Text] [Related]
40. Porphyrin NanoMetal-Organic Frameworks as Cancer Theranostic Agents.
Figueira F; Tomé JPC; Paz FAA
Molecules; 2022 May; 27(10):. PubMed ID: 35630585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
